138
Views
4
CrossRef citations to date
0
Altmetric
Nephrology

Expression of response gene to complement-32 in renal tissue of children with immunoglobulin A nephropathy

, , , , , , & show all
Pages 371-376 | Received 11 Feb 2011, Accepted 05 Apr 2011, Published online: 16 Jun 2011

References

  • Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213–17.
  • Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004;82:175–81.
  • Huang WY, Li ZG, Rus H, Wang X, Jose PA, Chen SY. Response gene to complement 32 mediates transforming growth factor β-induced epithelial–mesenchymal transition in human renal proximal tubular cells. J Biol Chem 2009;284:9426–32.
  • Churg J, Bernstein J, Glassock RJ. Renal disease classification and atlas of glomerular disease. New York: Ikagu Shoin Medical Publishers; 1995. p 4.
  • Katafuchi R, Kiyoshi Y, Oh Y, Uesugi N, Ikeda K, Yanase T, Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 1998;49:1–8.
  • Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009;76:546–56.
  • Badea TC, Niculescu FI, Soane L, Shin ML, Rus H. Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J Biol Chem 1998;273:26977–81.
  • Badea TC, Niculescu F, Soane L, Fosbrink M, Sorana H, Rus V, RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J Biol Chem 2002;277:502–8.
  • Fosbrink M, Cudrici C, Tegla CA, Soloviova K, Ito K, Vlaicu S, Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp Mol Pathol 2009;86:87–94.
  • Almon RR, Lai W, DuBois DC, Jusko WJ. Corticosteroid-regulated genes in rat kidney: mining time series array data. Am J Physiol Endocrinol Metab 2005;289:E870–82.
  • Jo M, Curry TE Jr. Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles. Mol Endocrinol 2006;20:2156–72.
  • Li F, Luo Z, Huang W, Lu Q, Wilcox S, Jose PA, Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells. J Biol Chem 2007;282:10133–7.
  • Strom CC, Aplin M, Ploug T, Christoffersen TE, Langfort J, Viese M, Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J 2005;272:2684–95.
  • Rozsa FW, Reed DM, Scott KM, Pawar H, Moroi SE, Kijek TG, Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis 2006;12:125–41.
  • Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007;145:3824–6.
  • Fosbrink M, Cudrici C, Niculescu F, Badea TC, David S, Shamsuddin A, Overexpression of RGC-32 in colon cancer and other tumors. Exp Mol Pathol 2005;78:116–22.
  • D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004;24:179–96.
  • Hastings MC, Delos Santos NM, Wyatt RJ. Renal survival in pediatric patients with IgA nephropathy. Pediatr Nephrol 2007;22:317–18.
  • Yata N, Nakanishi K, Shima Y, Togawa H, Obana M, Sako M, Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol 2008;23:905–12.
  • Haas M, Rahman MH, Cohn RA, Fathallah-Shaykh S, Ansari A, Bartosh SM. IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant 2008;23:2537–45.
  • Hotta O. Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy. Semin Nephrol 2004;24:244–55.
  • Utsunomiya Y, Kawamura T, Abe A, Imai H, Hirano K, Maruyama N, Significance of mesangial expression of alpha-smooth muscle actin in the progression of IgA nephropathy. Am J Kidney Dis 1999;34:902–10.
  • Silva GE, Costa RS, Ravinal RC, dos Reis MA, Dantas M, Coimbra. Mast cells, TGF-1 and α-SMA expression in IgA nephropathy. Dis Markers 2008;24:181–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.